Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Watanabe M, Nakamura Y, Michalak Z, Isobe N, et al. Neurology 2019;93:e1299-e1311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watanabe M, Nakamura Y, Michalak Z, Isobe N, et al. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 2019;93:e1299-e1311.
PMID: 31471502